<DOC>
	<DOCNO>NCT00345800</DOCNO>
	<brief_summary>To monitor endocrine change response treatment cataplexy Xyrem , focus hypothalamic pituitary axis confirm safety Xyrem potential endocrine change .</brief_summary>
	<brief_title>Exploratory Clinical Study Evaluate Sodium Oxybate ( Xyrem ) Potential Endocrine Changes</brief_title>
	<detailed_description />
	<mesh_term>Narcolepsy</mesh_term>
	<mesh_term>Cataplexy</mesh_term>
	<mesh_term>Sodium Oxybate</mesh_term>
	<criteria>Narcoleptic patient cataplexy Subjects diagnose narcolepsy cataplexy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Endocrine Evaluation cataplexy</keyword>
	<keyword>sodium oxybate ( xyrem )</keyword>
</DOC>